These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9358072)

  • 1. Recombinant human erythropoietin to assist autologous blood donation by patients with anemia.
    Cazzola M
    J Lab Clin Med; 1997 Oct; 130(4):354-6. PubMed ID: 9358072
    [No Abstract]   [Full Text] [Related]  

  • 2. Repeated continuous administration of low doses of intravenous iron in anemic patients with active rheumatoid arthritis.
    Höchli P; Wagenhäuser FJ; Fehr J
    Eur J Haematol; 1993 Jul; 51(1):54-5. PubMed ID: 8348948
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of recombinant human erythropoietin to assist autologous blood donation by anemic rheumatoid arthritis patients undergoing major orthopedic surgery.
    Mercuriali F; Gualtieri G; Sinigaglia L; Inghilleri G; Biffi E; Vinci A; Colotti MT; Barosi G; Lambertengh Deliliers G
    Transfusion; 1994 Jun; 34(6):501-6. PubMed ID: 8023392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous blood transfusion with recombinant erythropoietin treatment in anaemic patients with rheumatoid arthritis.
    Tanaka N; Ito K; Ishii S; Yamazaki I
    Clin Rheumatol; 1999; 18(4):293-8. PubMed ID: 10468168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of recombinant human erythropoietin [rHuEpo] in man.
    Adamson JW; Eschbach JW
    Prog Clin Biol Res; 1990; 352():505-17. PubMed ID: 2205875
    [No Abstract]   [Full Text] [Related]  

  • 6. Low-dose intravenous iron administration in chronic hemodialysis patients treated with recombinant human erythropoietin.
    Harmankaya O; Eran A
    Ren Fail; 2002 Mar; 24(2):245-7. PubMed ID: 12071600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of oral and intravenous iron supplementation in preterm infants receiving recombinant erythropoietin.
    Meyer MP; Haworth C; Meyer JH; Commerford A
    J Pediatr; 1996 Aug; 129(2):258-63. PubMed ID: 8765624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing severe anemia when the patient is a Jehovah's Witness.
    Lynn S; McDaniel J
    JAAPA; 2013 Apr; 26(4):24, 27-9. PubMed ID: 23610833
    [No Abstract]   [Full Text] [Related]  

  • 9. The effects of recombinant human erythropoietin on autologous blood donation in rheumatoid arthritis patients with anaemia.
    Matsui H; Shiraishi N; Yasuda T; Nezuka T
    Clin Exp Rheumatol; 1999; 17(1):69-74. PubMed ID: 10084035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of i.v. iron saccharate in haemodialysis patients not responding to oral iron and erythropoietin.
    al-Hawas F; Abdalla AH; Popovich W; Mousa DH; al-Sulaiman MH; al-Khader AA
    Nephrol Dial Transplant; 1997 Dec; 12(12):2801-2. PubMed ID: 9430909
    [No Abstract]   [Full Text] [Related]  

  • 11. Oral or intravenous iron as an adjuvant to autologous blood donation in elective surgery: a randomized, controlled study.
    Weisbach V; Skoda P; Rippel R; Lauer G; Glaser A; Zingsem J; Zimmermann R; Eckstein R
    Transfusion; 1999 May; 39(5):465-72. PubMed ID: 10335995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iatrogenic osteomalacia caused by intravenous administration of saccharated ferric oxide.
    Suzuki A; Ohoike H; Matsuoka Y; Irimajiri S
    Am J Hematol; 1993 May; 43(1):75-6. PubMed ID: 8317471
    [No Abstract]   [Full Text] [Related]  

  • 13. The dilemma of evaluating iron status in dialysis patients--limitations of available diagnostic procedures.
    Sunder-Plassmann G; Spitzauer S; Hörl WH
    Nephrol Dial Transplant; 1997 Aug; 12(8):1575-80. PubMed ID: 9269632
    [No Abstract]   [Full Text] [Related]  

  • 14. Interactions between erythropoietin and iron metabolism in anaemia of chronic disorders.
    Vreugdenhil G; Nieuwenhuizen C; Swaak AJ
    Eur J Haematol; 1992 Jan; 48(1):56-7. PubMed ID: 1730281
    [No Abstract]   [Full Text] [Related]  

  • 15. Serial estimation of serum interleukin 6 during treatment with recombinant human erythropoietin in patients with the anemia of rheumatoid arthritis.
    Jongen-Lavrencic M; Swaak AJ; Vreugdenhil G
    J Rheumatol; 1993 Jul; 20(7):1253-5. PubMed ID: 8371234
    [No Abstract]   [Full Text] [Related]  

  • 16. Correction of anaemia in rheumatoid arthritis by recombinant human erythropoietin.
    Tauchi T; Ohyashiki JH; Fujieda H; Lin KY; Ohyashiki K; Toyama K
    Br J Rheumatol; 1990 Jun; 29(3):235-6. PubMed ID: 2357513
    [No Abstract]   [Full Text] [Related]  

  • 17. [Budget impact analysis of a blood saving program for urgent traumatological surgery].
    Izuel Rami M; Gómez Barrera M; Villar Fernández I; Rabanaque Hernández MJ; Cuenca Espiérrez J; García-Erce JA
    Med Clin (Barc); 2007 Jan; 128(1):7-11. PubMed ID: 17266885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of intravenous iron sucrose for treatment of anaemia in pregnancy.
    Kalaivani K
    Indian J Med Res; 2013; 138(1):16-7. PubMed ID: 24056552
    [No Abstract]   [Full Text] [Related]  

  • 19. Recombinant human erythropoietin (r-hu-EPO) treatment in patients with rheumatoid arthritis and anaemia of chronic disease (ACD).
    Swaak AJ; Nieuwenhuizen C; Vreugdenhil G
    Clin Exp Rheumatol; 1994; 12(5):577. PubMed ID: 7842542
    [No Abstract]   [Full Text] [Related]  

  • 20. Intravenous iron supplementation for the treatment of the anemia of moderate to severe chronic renal failure patients not receiving dialysis.
    Silverberg DS; Iaina A; Peer G; Kaplan E; Levi BA; Frank N; Steinbruch S; Blum M
    Am J Kidney Dis; 1996 Feb; 27(2):234-8. PubMed ID: 8659499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.